Article
NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.
PloS one - 1 Jan 2017
Neukam Karin, Martínez Alfredo P, Culasso Andrés C A, Ridruejo Ezequiel, García Gabriel, Di Lello Federico A
Abstract excerpt
OBJECTIVE: To evaluate the use of hepatitis C virus (HCV) NS3 sequencing as alternative to the comercially available Versant HCV 2.0 reverse hybridization line-probe assay (LiPA 2.0) to determine HCV genotype 1 (HCV-1) subtypes. PATIENTS AND METHODS: A cohort of 104 patients infected by HCV-1 according to LiPA 2.0 was analyzed in a cross-sectional study conducted in patients seen from January 2012 to June 2016 at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
